New tool will compare costs and benefits of cancer treatments

LOS ANGELES (Reuters) - As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies.